Analysis of the European Hepatitis B and C Therapeutics Markets

Emerging Combinatorial Therapeutics is the Future Market

Regular Price: USD 4,950

Special Price USD 4,208

15% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 4,208

PAY BY INVOICE

Be the first to review this product

This research service gives an in-depth analysis of what lies next for the Hepatitis B and C therapeutics markets. This research service covers, the key trends, drivers, restraints, revenue forecasts and competitive analysis of the Hepatitis B and C therapeutics market along with the respective segments such as interferons, nucleoside analogues for Hepatitis B and SOC, protease inhibitors for Hepatitis C. A comprehensive European Regional analysis (The United Kingdom, Germany, France, Italy, Spain, Benelux and Scandinavia) and regional policy implications have also been provided.

Table of Contents

Executive SummaryExecutive SummaryExecutive Summary—Market Engineering MeasurementsExecutive Summary—Market Engineering Measurements (continued)Executive Summary—Market Engineering Measurements (continued)Executive Summary—Market Engineering Measurements (continued)Executive Summary—CEO’s PerspectiveMarket OverviewMarket Overview—Disease OverviewMarket Overview—Disease Overview (continued) Market Overview—Hepatitis B Definitions Market Overview—Key Questions This Study Will AnswerMarket Overview—Market SegmentationMarket Overview—Geographic SegmentationExternal Challenges: Drivers and Restraints—Hepatitis B and C Therapeutics MarketsDrivers and RestraintsDrivers ExplainedDrivers Explained (continued)Drivers Explained (continued)Restraints ExplainedRestraints Explained (continued)Restraints Explained (continued)Restraints Explained (continued)Impact Mapping of Drivers and RestraintsForecasts and Trends—Hepatitis B and C Therapeutics MarketsMarket Engineering MeasurementsMarket Engineering Measurements (continued)Forecast AssumptionsHepatitis B Therapeutics Market—Revenue ForecastHepatitis B Therapeutics Market—Revenue Forecast DiscussionHepatitis B Therapeutics Market—Revenue Forecast by Drug ClassHepatitis B Therapeutics Market—Revenue Forecast by RegionHepatitis B Therapeutics Market—Revenue Forecast by RegionHBV Surveillance SystemHBV Surveillance System (continued)Hepatitis B Therapeutics Market—Metrics AnalysisMarket Engineering MeasurementsMarket Engineering Measurements (continued)Hepatitis C Therapeutics Market—Revenue ForecastHepatitis C Therapeutics Market—Revenue Forecast DiscussionHepatitis C Therapeutics Market—Revenue Forecast by Drug ClassHepatitis C Therapeutics Market—Revenue Forecast by RegionHepatitis C Therapeutics Market—Revenue Forecast by Region (continued)HCV Surveillance SystemHCV Surveillance System (continued)Hepatitis C Therapeutics Market—Metrics AnalysisPEST AnalysisDemand Analysis—Hepatitis B and C Therapeutics MarketsHepatitis B—Infection Prevalence AnalysisHepatitis C—Infection Prevalence AnalysisMarket Share and Competitive Analysis— Hepatitis B and C Therapeutics MarketsCompetitive Analysis—Market ShareMarket Share AnalysisCompetitive EnvironmentCompetitive Analysis—Market ShareMarket Share AnalysisCompetitive EnvironmentHepatitis B—Key Marketed Product AnalysisHepatitis B—Key Pipeline Analysis Hepatitis B—Key Pipeline Analysis (continued) Hepatitis C—Marketed Product AnalysisHepatitis C—Marketed Product Analysis (continued)Hepatitis C—Key Pipeline Analysis Pipeline AnalysisHepatitis C—Key Pipeline Analysis—Interferon-free CombinationsHepatitis B—Segment BreakdownInterferon Segment BreakdownInterferons Segment BreakdownInterferons Segment—Market Engineering MeasurementsInterferons Segment—Revenue ForecastInterferons Segment—Revenue Forecast DiscussionInterferons Segment—Impact of Key Market TrendsNucleoside Analogues Segment BreakdownNucleoside Analogues Segment BreakdownNucleoside Analogues Segment—Market Engineering MeasurementsNucleoside Analogues Segment—Revenue ForecastNucleoside Analogues Segment—Revenue Forecast DiscussionNucleoside Analogues Segment—Impact of Key Market TrendsHepatitis C Segment BreakdownSOC Segment Breakdown(Peginterferon alfa and Ribavirin) SOC Segment BreakdownSOC Segment—Market Engineering MeasurementsSOC Segment—Revenue ForecastSOC Segment—Revenue Forecast DiscussionSOC Segment—Impact of Key Market TrendsProtease Inhibitors Segment BreakdownProtease Inhibitors Segment BreakdownProtease Inhibitors Segment—Market Engineering MeasurementsProtease Inhibitors Segment—Revenue ForecastProtease Inhibitors Segment—Revenue Forecast DiscussionProtease Inhibitors Segment—Impact of Key Market TrendsSegment Breakdown By GeographyUK BreakdownUK Market—IntroductionUK Hepatitis B Therapeutics Market—Market Engineering MeasurementsUK Hepatitis B Therapeutics Market—Revenue ForecastUK Hepatitis C Therapeutics Market—Market Engineering MeasurementsUK Hepatitis C Therapeutics Market—Revenue ForecastUK Hepatitis B and Hepatitis C Therapeutics Markets—Revenue Forecast DiscussionUK Hepatitis B and C Therapeutics Markets—Policies and ImplicationsGermany BreakdownGerman Market—IntroductionGerman Hepatitis B Therapeutics Market—Market Engineering MeasurementsGerman Hepatitis B Therapeutics Market—Revenue ForecastGerman Hepatitis C Therapeutics Market—Market Engineering MeasurementsGerman Hepatitis C Therapeutics Market—Revenue ForecastGerman Hepatitis B and Hepatitis C Drugs Markets—Revenue Forecast DiscussionGerman Hepatitis B and Hepatitis C Therapeutics Markets —Policies and ImplicationsFrance BreakdownFrench Market—IntroductionFrench Hepatitis B Therapeutics Market—Market Engineering MeasurementsFrench Hepatitis B Therapeutics Market—Revenue ForecastFrench Hepatitis C Therapeutics Market—Market Engineering MeasurementsFrench Hepatitis C Therapeutics Market—Revenue ForecastFrench Hepatitis B and Hepatitis C Therapeutics Markets—Revenue Forecast DiscussionFrench Hepatitis B and C Therapeutics Markets—Policies and ImplicationsSpain BreakdownSpanish Market—IntroductionSpanish Hepatitis B Therapeutics Market—Market Engineering MeasurementsSpanish Hepatitis B Therapeutics Market—Revenue ForecastSpanish Hepatitis C Therapeutics Market—Market Engineering MeasurementsSpanish Hepatitis C Therapeutics Market—Revenue ForecastSpanish Hepatitis B and Hepatitis C Therapeutics Markets—Revenue Forecast DiscussionSpanish Hepatitis B and C Therapeutics Markets—Policies and ImplicationsItaly BreakdownThe Italian Market—IntroductionItalian Hepatitis B Therapeutics Market—Market Engineering MeasurementsItalian Hepatitis B Therapeutics Market—Revenue ForecastItalian Hepatitis C Therapeutics Market—Market Engineering MeasurementsItalian Hepatitis C Therapeutics Market—Revenue ForecastItalian Hepatitis B and Hepatitis C Therapeutics Markets—Revenue Forecast DiscussionItalian Hepatitis B and C Therapeutics Markets—Policies and ImplicationsBenelux BreakdownBenelux Market—IntroductionBenelux Hepatitis B Therapeutics Market—Market Engineering MeasurementsBenelux Hepatitis B Therapeutics Market—Revenue ForecastBenelux Hepatitis C Therapeutics Market—Market Engineering MeasurementsBenelux Hepatitis C Therapeutics Market—Revenue ForecastBenelux Hepatitis B and Hepatitis C Therapeutics Markets—Revenue Forecast DiscussionBelgium Hepatitis B and C Therapeutics Markets—Policies and ImplicationsThe Netherlands Hepatitis B and C Therapeutics Markets—Policies and Implications (continued)Luxembourg Hepatitis B and C Therapeutics Markets—Policies and ImplicationsScandinavia BreakdownScandinavian Market—IntroductionScandinavia Hepatitis B Therapeutics Market—Market Engineering MeasurementsScandinavia Hepatitis B Therapeutics Market—Revenue ForecastScandinavia Hepatitis C Therapeutics Market—Market Engineering MeasurementsScandinavia Hepatitis C Therapeutics Market—Revenue ForecastScandinavia Hepatitis B and Hepatitis C Therapeutics Markets—Revenue Forecast DiscussionNorway Hepatitis B and C Therapeutics Markets—Policies and ImplicationsDenmark Hepatitis B and C Therapeutics Markets—Policies and ImplicationsFinland Hepatitis B and C Therapeutics Markets—Policies and ImplicationsSweden Hepatitis B and C Therapeutics Markets—Policies and ImplicationsThe Last WordConclusions—Hepatitis B and C Therapeutics MarketsThe Last Word—Three Big PredictionsLegal DisclaimerAppendixMarket Engineering MethodologyDatabase of Key Industry ParticipantsAdditional Sources of InformationTable of Acronyms UsedIncidence of Hepatitis BLiver Failure DeathsGovernment Healthcare ExpenditureTotal Healthcare Expenditure




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.